CorMedix (CRMD) Prepaid Assets (2010 - 2026)
CorMedix (CRMD) posted Prepaid Assets of $2.0 million for Q4 2025, up 28.2% sequentially from $1.5 million in Q3 2025, and down 45.58% YoY from $3.6 million in Q4 2024.
CorMedix (CRMD) Prepaid Assets (2010 - 2026) Analysis & Trends
CorMedix has reported Prepaid Assets for 15 years, with the latest figure at $2.0 million in Q4 2025.
- Quarterly Prepaid Assets fell 45.58% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (down 45.58% YoY) and the FY2025 annual result came in at $2.0 million, down 45.58% from the prior year.
- Prepaid Assets grew to $2.0 million in Q4 2025 per CRMD's latest filing, from $1.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $3.6 million in Q4 2024 and troughed at $2910.0 in Q1 2023.
- A 5-year average of $773112.6 and a median of $93882.0 in 2021 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets surged 74342.16% in 2024, then slumped 97.24% in 2025.
- Over 5 years, Prepaid Assets stood at $51993.0 in 2021, then tumbled by 78.81% to $11016.0 in 2022, then soared by 972.0% to $118091.0 in 2023, then jumped by 2976.44% to $3.6 million in 2024, then plunged by 45.58% to $2.0 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $2.0 million, $1.5 million, and $123116.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.97 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 123,116.00 |
| Mar 31, 2025 | 59,836.00 |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 211,509.00 |
| Mar 31, 2024 | 2.17 Mn |
| Dec 31, 2023 | 118,091.00 |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 2,910.00 |
| Dec 31, 2022 | 11,016.00 |
| Sep 30, 2022 | 19,123.00 |
| Jun 30, 2022 | 28,451.00 |
| Mar 31, 2022 | 40,222.00 |
| Dec 31, 2021 | 51,993.00 |
| Sep 30, 2021 | 63,764.00 |
| Jun 30, 2021 | 36,480.00 |